Post

New research · Ophthalmology
American journal of ophthalmology · 17h
StudyAmerican journal of ophthalmology · 2026

Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma.

Daniela Vaisman, Jacob Pe'er, Maya Eiger-Moscovich … Shahar Frenkel
Read paper
OphthalmologyStudy

Topical interferon alfa-2a produced complete clinical response in most primary acquired melanosis with atypia cases.

Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma.

Daniela Vaisman … Shahar Frenkel
American journal of ophthalmology · 2026
Purpose

To report on topical treatment with interferon (interferon) alfa-2a for conjunctival primary acquired melanosis (primary acquired melanosis) with atypia.

Methods

Received topical interferon α-2a, interferon α-2b, or pegylated interferon α-2a.

n = 12 patients
93%
Results
93%
treatment cleared the abnormal cells completely in nearly all patients
n = 12 patients
More results

The average PFS was 52.5 months (4.3 years), with only one patient experiencing recurrence after 13 months.

Treatment was well tolerated; five patients reported mild adverse effects, including dry eye, redness, and blurred vision.

Two patients experienced more severe side effects, leading to treatment discontinuation.

More results

No limbal stem cell damage was observed in patients treated with interferon alone.

“
Conclusion · 1 of 2

Topical interferon α-2a is safe and effective for treating primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma that arises from primary acquired melanosis with atypia, with high response rates and little to no toxicity.

Conclusion · 2 of 2

Its similarity to interferon α-2b and safety profile make interferon α-2a a good alternative. Further large-scale, controlled studies are needed to validate these findings and their role in clinical practice.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving